论文部分内容阅读
Drug Safety Information Disclosure
【出 处】
:
2008药品安全与公共政策国际研讨会
【发表日期】
:
2008年12期
其他文献
Nadir prostate-specific antigen predicts androgen-independent progression after endocrine therapy in
Transurethral bipolar plasmakinetic resection of prostate in treatment of benign prostatic hyperplas
A retrospective study on prostatic histological inflammation of 1257 benign prostatic hyperplasia ca
Prevalence of benign prostate hyperplasia and its relative factors in rural areas of Tianjin in 2008